June 27, 2014
Fitch Even attorney Alisa C. Simmons has been voted President-Elect of the Intellectual Property Law Association of Chicago (IPLAC) for 2014–15. Alisa’s practice includes U.S. and international trademark portfolio management, as well as copyright, advertising, social media, and Internet-related IP issues. She recently assisted a trade association with selecting and clearing a new brand name to be used with telecommunication hardware and software in the U.S., Europe, Asia, and South America.
Fitch Even partner Joseph T. Nabor was reappointed Chair of IPLAC’s Historical Records Committee for 2014–15. Joe has chaired the firm’s Trademark and Copyright practice group since 1989.
Fitch Even partner Joseph E. Shipley, who served as IPLAC President for the 2008–09 bar year, will continue as IPLAC’s delegate to the U.S. Bar–EPO Liaison Council and as Vice-Chair of the International Patent Committee for 2014–15.
Fitch Even senior paralegal Cindi Schermerhorn was reappointed Co-Chair of the Paralegal Committee for the current bar year. Cindi has been serving in this role since the committee’s inception in 2011.
Founded in 1884, IPLAC is the oldest intellectual property law association in the United States. Fitch Even attorneys have served as leaders and members of the organization since its inaugural meeting.
IP Alert | Knowledge Within the Art Does Not Save Means-Plus-Function Claim Term Lacking Corresponding StructureFebruary 19, 2021
On February 12, in Synchronoss Technologies, Inc. v. Dropbox, Inc., the Federal Circuit affirmed that certain of Synchronoss's claims were invalid for indefiniteness, since the claims included a means-plus-function claim term that did not have adequate structural support in the specification. Read more
IP Alert | Customer Loyalty Program Does Not Claim Patent-Eligible Subject MatterFebruary 16, 2021
On February 8, in cxLoyalty, Inc v. Maritz Holdings, Inc., the Federal Circuit invalidated a patent for failure to claim patentable subject matter, reversing findings of the PTAB relating to substitute claims in a CBM review. Read more